Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors

ABSTRACT:

SUBMITTER: Chang M 

PROVIDER: S-EPMC12294753 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature